Loading

Balancing Global Opportunities and Trade Policy Risks

March 02, 2026
Pompeii Ballroom
Type: Educational Session
More than a third of U.S. licensing deals this year have involved assets sourced from China and investment is adjusting in response. As deal activity accelerates, regulatory scrutiny has intensified. This session will examine valuation impacts, evolving deal structures, and regulatory considerations related to cross border investment trends and how they affect U.S. firms’ planning in an active tariff environment.
Moderator
Kelly Seagraves
Vice President, National Security & International Affairs
Biotechnology Innovation Organization (BIO)
Speakers
Daniel Brog
Managing Director
Locust Walk
Anthony Japour
CEO and President
iTolerance, Inc.
Arda Ural
Americas Life Sciences Leader
Ernst & Young, LLP